GGG delivered its Q1 2026 results on April 22 and the market's verdict was swift. The stock fell nearly 6% on the day and extended that slide to almost 9% over the following five sessions, closing the week at $79.57 — down 7% on the week and 5% on the month.
The most striking backdrop to that earnings reaction is what insiders were doing in the weeks immediately before it. The insider story here is hard to ignore. CEO Mark Sheahan sold 40,219 shares at $86.83 on January 29 for roughly $3.5 million. CFO David Lowe sold 38,325 shares on the same day for $3.3 million. Several divisional presidents followed suit through early February, with the cluster totalling well over $11 million in net insider sales across 90 days. Against that, a single director — Andrea Simon — bought 1,240 shares at $80.53 on April 27, just days after the post-earnings drop, a token $100,000 purchase that barely registers against the broader wave of selling at materially higher prices.
The borrow market offers no meaningful squeeze angle. Short interest has drifted lower all week, easing from 2.21% of the free float to 2.11% — the lowest level in the tracked period. Availability is deep, and cost to borrow has edged up to 0.55% on the year's most recent reading, which is up roughly 85% over the month but still trivially low in absolute terms. The lending pool is wide open; there is no pressure on the short side of the trade. What stands out instead is the options picture, where traders have turned decisively bullish in the wake of the selloff. The put/call ratio dropped to 0.12, well below its 20-day average of 0.27 and near the low end of a 52-week range that reaches as high as 1.59. That is more than one standard deviation below the recent mean, pointing to a market that is reaching for call exposure rather than hedging with puts — an unusual posture immediately after a sharp earnings-driven decline.
The analyst community is cautious rather than alarmed. Baird lowered its target from $96 to $92 on April 24, the day of the formal earnings event, while maintaining a Neutral rating. DA Davidson held its Neutral rating and $85 target the following day. The mean Street target now sits at $92, implying roughly 14% upside from current levels — but the direction of travel on targets has been down, not up. At a P/E of approximately 25x and EV/EBITDA of around 16x, GGG is not cheap for a name where the forward EPS picture is deteriorating: the 30-day EPS momentum factor ranks in only the 15th percentile. The RSI-14 has compressed to 32, signalling the stock is in oversold territory on a short-term technical basis. Peers are offering a mixed read — IEX gained nearly 7% on the week and ASTE added 5.8%, while IR fell 7.5% and ITW was roughly flat, suggesting the weakness is more company-specific than sector-wide.
With no confirmed next earnings date in the data, the near-term focus for GGG shifts to whether the post-Q1 repricing has run its course, or whether the muted analyst response and softening EPS revisions sustain further multiple compression. The divergence between call-heavy options positioning and the downward-sloping analyst revision trend is the tension worth watching.
See the live data behind this article on ORTEX.
Open GGG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
